Hikma Pharmaceuticals PLC
HIK
Rangering i aksjer
#25470
Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the... Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the creation, production, promotion, and distribution of a wide array of generic, branded, and licensed medicinal solutions. These offerings are presented in various dosage formats, including solid, semi-solid, liquid, and injectable forms. The company's operations are strategically structured into three core segments: Injectables, Generics, and Branded. The Injectables division specializes in providing generic injectable medications, predominantly for hospital environments. Conversely, the Generics segment is responsible for supplying oral and other non-injectable generic pharmaceuticals to the consumer retail market. The Branded unit caters to both retail and hospital clients with its proprietary generic and in-licensed products. Hikma's comprehensive product portfolio addresses a broad spectrum of medical conditions, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory ailments. The firm boasts a substantial international presence, conducting business across the United Kingdom, the United States, the Middle East, North Africa, and various European countries. Founded in 1978, the company's corporate headquarters are situated in London, United Kingdom.
Aksjekurs
$22.61
Sist synkronisert: 2026-10-19
Markedsverdi
$46.82M
Endring (1 dag)
0.48%
Endring (1 år)
-52.26%
Land
GB
Handel Hikma Pharmaceuticals PLC (HIK)
Kategori
Healthcare
Markedsverdi av Hikma Pharmaceuticals PLC(HIK)
Markedsverdi: $46.82M
Per October 2026 har Hikma Pharmaceuticals PLC en markedsverdi på $46.82M. Dette gjør Hikma Pharmaceuticals PLC til det 25470th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Hikma Pharmaceuticals PLC fra 2011 til 2026
HIK sammenlignet med topp 5 mest populære stocks
